APA

Nauck M. A., Heimesaat M. M., Orskov C., Holst J. J., Ebert R. & Creutzfeldt W. (19930224). Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. : The Journal of clinical investigation.

Chicago

Nauck M A, Heimesaat M M, Orskov C, Holst J J, Ebert R and Creutzfeldt W. 19930224. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. : The Journal of clinical investigation.

Harvard

Nauck M. A., Heimesaat M. M., Orskov C., Holst J. J., Ebert R. and Creutzfeldt W. (19930224). Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. : The Journal of clinical investigation.

MLA

Nauck M A, Heimesaat M M, Orskov C, Holst J J, Ebert R and Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. : The Journal of clinical investigation. 19930224.